Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation  by Azzollini, Nadia et al.
Propionyl-L-carnitine prevents early graft dysfunction
in allogeneic rat kidney transplantation
Nadia Azzollini1,2, Daniela Cugini1,2, Paola Cassis1,2, Anna Pezzotta1,2, Elena Gagliardini1, Mauro Abbatel,
Arduino Arduini3, Alessandro Peschechera4, Giuseppe Remuzzi1,2 and Marina Noris1,2
1Department of Immunology and Organ Transplantation, Ospedali Riuniti—Mario Negri Institute for Pharmacological Research,
Bergamo, Italy; 2Center for Research on Organ Transplantation, ‘Chiara Cucchi De Alessandri and Gilberto Crespi’, Ranica, Italy; 3R&D
Department, Iperboreal Pharma, Chieti, Italy and 4Department of Endocrinology and Metabolism, Sigma Tau Pharmaceuticals, Pomezia,
Italy
Ischemia-reperfusion injury is an important cause of graft
failure. Because carnitine regulates substrate flux and energy
balance across membranes which may be deranged in
ischemia we determined whether its use was effective in
preventing kidney injury in an allogeneic transplant model.
Brown Norway rats received a Lewis rat kidney transplant
and were then treated with cyclosporine A to avoid rejection.
The grafts were stored in Belzer solution supplemented with
propionyl-L-carnitine during the cold ischemia period.
Compared to rats receiving untreated kidneys but with equal
cold ischemia times, the post-transplant serum creatinine
values of the carnitine-treated transplants were significantly
lower. Histological evaluation 16 h after transplant showed
that propionyl-L-carnitine significantly inhibited tubular
necrosis and neutrophil infiltration of the allografts and
improved the 3 month graft survival. Treated transplants also
had decreased lipid peroxidation, inducible nitric oxide
synthase expression and protein nitration compared to the
untreated grafts. Post-transplant serum creatinine levels were
significantly reduced and graft survival was slightly
prolonged in rats not receiving cyclosporine A treatment and
transplanted with a kidney treated with propionyl-L-carnitine.
The efficacy of propionyl-L-carnitine to modulate
ischemia-reperfusion injury during transplantation suggests
that its use in human transplantation is worth testing.
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Worldwide 20–40% of patients who are given a cadaveric
renal graft suffer from impaired or delayed graft function in
the first few weeks after transplantation which mostly reflects
acute tubular necrosis due to peritransplant ischemia-
reperfusion (I/R) injury.1 Patients transplanted with organs
undergoing a longer cold I/R time have a higher risk of early
post-transplant complications including acute rejection, and
their long-term graft outcome is considerably less favor-
able.2–4 Thus every effort to achieve immediate diuresis and
function after transplantation is of great clinical relevance.
Oxidative damage is recognized to be a key process in
tissue damage that follows an ischemic insult.5,6 In hypoxic
cells, mitochondrial dysfunction leads to calcium accumula-
tion and activation of proteases that augment xanthine
oxidase production, which in turn, forms oxygen free
radicals. Endothelial cells are induced by ischemic damage
to express high levels of surface adhesion molecules and to
produce cytokines and chemokines capable to attract
neutrophils and macrophages, then promoting a nonspecific
host inflammatory response.7 Vasoactive mediators, lysoso-
mal enzymes, and superoxide anions released by activated
granulocytes concur to amplify the injury.8 Indirect evidence
in support to the above sequence of events rests on the
protective effect of free radical scavengers in experimental
models of I/R injury.9–13
Despite significant advances in understanding its patho-
physiology, the prevention and treatment of postischemic
injury remain one of the most difficult areas of kidney
transplant medicine with very modest achievements after
years of trials.
Carnitine is an essential cofactor required for the
translocation of activated long-chain fatty acids from
extramitochondrial coenzyme A into the inner mitochondrial
matrix and then to intramitochondrial coenzyme A.14 This
transport is essential to allow mitochondrial b-oxidation of
long-chain fatty acids and thus to provide energy supply to
the cells. Therefore, carnitine is an important factor in
regulating substrate flux and energy balance across cell
membranes, which might become critical in the context of
I/R, possibly preventing cell injury. Support for such
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possibility is provided by findings that L-carnitine has
protective properties in heart I/R injury in dogs.15
Propionyl-L-carnitine (PC), a short-chain acyl derivative
of L-carnitine, has the potential not only to restore tissue
carnitine stores but also to replenish key mitochondrial
tricarboxylic acid intermediates as documented by studies in
skeletal muscle mitochondria16 and in ischemic heart
tissues.17 In human subjects with preexisting ventricular
dysfunction, PC administration improved myocardial con-
tractility and function.18,19 PC also protected ischemic
myocardium and stimulated contractile recovery during
reperfusion in animal models.20–22 Intravenous administra-
tion of PC to hemodialysis patients with peripheral arterial
disease improved both the hemodynamic flow and the
oxidative profile.23
We previously documented that PC prevented renal
function deterioration and structural injury induced by I/R
in a rat model of isolated perfused kidney and in vivo in a
model of syngeneic kidney transplantation.24
This study was aimed to investigate whether PC were
effective in reducing I/R injury in an allogeneic kidney
transplant setting and to study the biochemical mechanisms
underlying the protective effect. For this purpose we set up a
model of kidney graft I/R injury in the fully mismatched
Lewis (LW) to Brown Norway (BN) rat strain combination,
in which recipient rats were daily treated with cyclosporine A
(CsA) to avoid acute rejection. It has been suggested that the
tissue injury caused in the graft by I/R might be important in
amplifying the response of T cells to alloantigens, thus
facilitating allograft rejection.25 Thus, a further aim of this
study was to examine whether cold ischemia damage could
accelerate allograft rejection in LW-BN rat model when no
immunosuppression was given, and whether this phenom-
enon could be prevented by addition of PC during cold
storage.
RESULTS
Effect of PC on I/R-induced graft dysfunction
To evaluate the effect of PC on I/R-induced graft dysfunction
in allogeneic transplantation, LW kidneys were transplanted
into BN recipients who were treated chronically with CsA
(10 mg/kg/day i.m., starting from the day of transplant;
Figure 1, left panel). In BN rats receiving a LW kidney
allograft not preexposed to cold ischemia (group 1), a slight
but statistically significant elevation (Po0.05) of serum
creatinine levels was observed at 16 and 24 h as compared to
pretransplant values (basal), likely due to warm ischemia
damage (Figure 2). However in all animals in this group,
serum creatinine values returned to basal levels within 2 days,
and remained normal until the end of the 90 days
observation period. Accordingly, in this group animal
survival was 100% (Figure 3). In animals receiving kidneys
preexposed to 6 h cold ischemia time (CIT) in Belzer solution
alone (group 2), serum creatinine increased soon after
surgery reaching values that, at 16 h, 24 h, and 2 days post
transplantation, were significantly higher (Po0.01) than
those observed in the control group 1 (Figure 2). In three out
of five animals of group 2, I/R-induced renal dysfunction was
irreversible and the animals died of renal failure at days 12,
18, and 24 post transplantation (Figure 3). In the other two
animals, serum creatinine levels progressively decreased
thereafter, reaching values of group 1 at day 15 post
transplantation. In animals receiving allogeneic kidneys
stored in Belzer solution added with 1.2 mg/ml PC during
Effect of PC on I/R-induced graft dysfunction Effect of PC on acute allograft rejection
Tx LW kidney Tx LW kidney
Csa 10mg/kg/day i.m.
Csa 10mg/kg/day i.m.
Csa 10mg/kg/day i.m.
16 h 90 days
Tx Lw kidney with 6 h CIT in Belzer Tx LW kidney with 6 h CIT in Belzer
Tx LW kidney with 6 h CIT in Belzer+PCTx Lw Kidney with 6 h CIT in Belzer+PC
Group 1
BN rat BN rat
∗
∗
∗
°
°
°
BN rat BN rat
BN ratBN rat
Group 2
Group 3
∗n=5 animals for each group killed at 16 h post-transplant
°killing at 90 days post-transplant
Group 4
Group 5
Group 6
Figure 1 | Experimental design. Left panel: to evaluate the effect of PC in I/R injury in allotransplantation, the following experimental
groups of animals were considered: group 1 (n¼ 8), rat recipients of a kidney allograft not exposed to cold ischemia time (CIT); group 2
(n¼ 10), rat recipients of a kidney allograft exposed to 6 h CIT in Belzer UW solution; group 3 (n¼ 10), rat recipients of a kidney allograft
exposed to 6 h CIT in Belzer UW solution containing PC (1.2 mg/ml). To prevent acute rejection, all rats received CsA (10 mg/kg/day i.m.)
starting from the day of transplant until the end of follow-up. Five animals in each group were killed 16 h after transplant for graft histology,
intragraft infiltration, energy charge, and oxidative damage evaluation. The other animals were followed for 90 days, to evaluate the effect
of PC on graft and animal survival and on chronic renal function preservation. Right panel: to investigate whether the addition of PC to the
preservation solution might delay allograft rejection, the following experimental groups of animals have been considered, to which no
immunosuppression was given: group 4 (n¼ 4), rat recipients of a kidney allograft not exposed to CIT; group 5 (n¼ 8), rat recipients of a
kidney allograft exposed to 6 h CIT in Belzer UW solution; group 6 (n¼ 10), rat recipients of a kidney allograft exposed to 6 h CIT in Belzer
UW solution containing PC (1.2 mg/ml). Animals were followed until rejection.
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6 h CIT (group 3), serum creatinine values at 16 h, 24 h, and 2
days post transplantation were significantly lower than values
observed in animals receiving an untreated ischemic
allogeneic kidney (16 h: Po0.01, 24 h and 2 days: Po0.05).
In addition, in group 3 serum creatinine levels returned to
control values at day 5 post transplantation. PC treatment
resulted in improved graft survival, indeed all the animals in
group 3 were alive at the end of the 90 days observation
period, so that the percent survival in animals of group 3 was
significantly higher than that of animals receiving untreated
kidneys exposed to CIT (100 vs 40%, Po0.05; Figure 3).
Effect of PC on I/R-induced graft histology changes and
intragraft cell infiltration
Histological examination of sections from allogeneic kidneys
was undertaken in a subgroup of animals killed 16 h post
transplantation (Figure 4). A mild–to-moderate tubular
necrosis was found in the outer medulla of grafts not
exposed to cold ischemia (group 1). Kidneys preexposed to
CIT (group 2) showed moderate–to-severe tubular necrosis
manifested by swollen, vacuolated proximal tubular cells with
pycnotic nuclei and denudation of tubular basement
membrane, mainly in the outer medulla. When PC was
added to the Belzer solution during CIT (group 3), a
significantly (Po0.05) lower degree of tubular necrosis at
16 h post transplantation was observed as compared with
group 2 grafts.
Figure 5a summarizes the results of quantitative evalua-
tion of granulocyte numbers by immunoflorescence. In
groups 1 and 2 allografts, higher numbers of granulocytes
were found in the interstitium at 16 h post transplantation, as
compared with those found in nontransplanted kidneys.
Interstitial granulocyte numbers were comparable in kidneys
from groups 1 and 2, indicating that warm ischemia induced
granulocyte recruitment in the graft and that cold ischemia
did not have an additive effect on this phenomenon.
Addition of PC to the storage solution completely prevented
granulocyte infiltration in the interstitial area of allogeneic
kidneys (Po0.01 vs groups 1 and 2; Figure 5a). Low numbers
of granulocytes were found in intra and periglomerular areas
and in perivascular area in all groups.
Some CD4þ lymphocytes and MHC IIþ cells were
found in the interstitium of groups 1 and 2 kidney allografts
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Figure 3 | Effect of PC on graft survival. Graft survival of BN rats
treated with CsA and receiving a Lewis kidney allograft not
preexposed to CIT (group 1, white squares; n¼ 3) or preexposed
to 6 h CIT in Belzer solution (group 2, black squares, n¼ 5) or in
Belzer solution added with PC (group 3, gray squares, n¼ 5).
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Figure 4 | Histological examination of tissue damage. Tubular
necrosis (score) at 16 h post transplant in kidneys of BN rats
treated with CsA and receiving a Lewis kidney allograft not
preexposed to CIT (group 1, white bars, n¼ 5) or preexposed to
6 h CIT in Belzer solution (group 2, black bars, n¼ 5) or in Belzer
solution added with PC (group 3, gray bars, n¼ 5) or in native
tissue kidneys (hatched bars, n¼ 3). Values are mean±s.d.
wPo0.05 vs group 2, yPo0.05 vs native kidneys.
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Figure 2 | Effect of PC on I/R induced graft dysfunction. Serum
creatinine levels in BN rats treated with CsA and receiving a Lewis
kidney allograft not preexposed to CIT (group 1, white bars, n¼ 8
till 16 h, n¼ 3 thereafter) or preexposed to 6 h CIT in Belzer
solution (group 2, black bars, n¼ 10 till 16 h, n¼ 5 till 12 days,
n¼ 4 till 18 days, n¼ 3 till 24 days, n¼ 2 thereafter) or in Belzer
solution added with PC (group 3, gray bars, n¼ 10 till 16 h, n¼ 5
thereafter). Five animals in each group were killed 16 h after
transplant; the other animals were followed for 3 months. In
group 2, three animals died of renal failure at days 12, 18, and 24
post transplant. Values are mean±s.d. 1Po0.01 vs group 1,
#Po0.05 vs group 1, *Po0.01 vs group 2, wPo0.05 vs group 2,
$Po0.05 vs basal.
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(Figure 5b). In PC-treated kidneys (group 3), lower numbers
of infiltrating CD4þ lymphocytes and MHCþ cells were
found, although the difference among groups did not reach
statistical significance. Very few CD8þ lymphocytes and
ED1þ monocytes/macrophages were found in the interstitium
of kidney allografts, with no difference among groups.
Effect of PC on I/R-induced oxidative tissue damage
To evaluate whether the I/R damage in kidney grafts was
associated with increased oxidative stress and whether the
protective effect of PC was related to an antioxidant effect,
analysis of lipid peroxidation products was undertaken in
renal tissues 16 h after transplantation. The amount and
distribution of 4-hydroxynonenal (4-HNE)-modified pro-
teins, formed by a major aldehydic product of lipid
peroxidation (4-HNE) and the lysine residues of structural
proteins,26 were assessed using a specific antibody. 4-HNE-
lysine staining was very faint in tubuli, glomeruli, and vessels
(both arterioles and venules) of nontransplanted kidneys,
whereas signals were intense in kidney sections from both
group 1 and group 2 animals (Figure 6). In PC-treated grafts
(group 3), 4-HNE-lysine staining scores in all areas examined
were significantly lower then those in groups 1 and 2. Of
note, in tubuli and vessels of group 3 kidneys, the amount of
lipid peroxidation was not different from that found in
nontransplanted kidneys.
To evaluate whether the expression of inducible nitric
oxide enzyme (iNOS) was upregulated following ischemic
injury in kidney grafts, analysis of iNOS mRNA levels in the
grafts was performed at the same time post transplantation.
The expression of iNOS was only slightly enhanced in group
1 kidneys in respect to native kidneys (Figure 7a); by contrast
iNOS expression was significantly higher (Po0.05) in group
2 kidneys exposed to CIT in respect to native and group 1
kidneys. PC completely blocked iNOS expression upregula-
tion (group 3 Po0.01 vs group 2) so that in group 3 grafts
iNOS levels were comparable to those recorded in native
nontransplanted kidneys (Figure 7a).
High amounts of free oxygen radicals in the presence of
nitric oxide could generate toxic products such as peroxini-
trite, whose formation can be detected by measuring the
extent of protein nitration by nitrotyrosine staining.27 This
was done in kidneys from rats killed 16 h post transplanta-
tion. As shown in Figure 7b, kidney grafts undergoing cold
ischemia in Belzer solution alone were more markedly
stained by an antinitrotyrosine antibody in tubuli, glomeruli,
and vessels (both arterioles and venules) than native kidneys
and kidney grafts not exposed to CIT. Staining for
nitrotyrosine in kidneys from group 3 treated with PC was
significantly lower in tubuli (Po0.01), glomeruli (Po0.01),
and vessels (Po0.01) than in kidneys from group 2 and not
different from that found in native kidneys. Altogether the
data indicate that PC added to Belzer solution during CIT
prevented lipid peroxidation, iNOS upregulation and perox-
initrite generation.
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Figure 5 | Analysis of graft infiltrating cells. Immunohistochemical staining at 16 h post transplant in kidneys from animals treated
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Figure 6 | Immunocytochemistry of 4-hydroxynonenal protein
adducts. 4-HNE lysine immunoperoxidase staining mean score in
kidney tissues from rats treated with CsA and receiving a kidney
allograft not preexposed to CIT (group 1, white bars, n¼ 5) or
preexposed to 6 h CIT in Belzer solution (group 2, black bars,
n¼ 5) or in Belzer solution added with PC (group 3, gray bars,
n¼ 5) or in native tissue kidneys (hatched bars, n¼ 3). Values are
mean±s.d. 1Po0.01 vs group 1, #Po0.05 vs group 1, *Po0.01 vs
group 2, &Po0.01 vs native kidneys, yPo0.05 vs native kidneys.
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Effect of PC on acute allograft rejection
We then investigated whether I/R damage had an impact on
the severity of acute allograft rejection.25 For this purpose BN
rats received an allogeneic LW kidney transplant preexposed
or not to 6 h CIT, but were not given CsA immunosuppres-
sion (Figure 1, right panel).
In animals receiving untreated kidneys exposed to CIT
(group 5), serum creatinine increased soon after surgery
reaching values that, at 16, 24 h and 2 days post transplanta-
tion, were significantly higher (Po0.01, Po0.05, Po0.05,
respectively) than those observed in a control group of
animals receiving a nonischemic allogeneic kidney transplant
(group 4; Figure 8a). In animals of group 5, serum creatinine
decreased in the following days and within 5 days reached
mean values comparable to those recorded in rats of group 4.
Serum creatinine increased thereafter in both groups due to
acute rejection that occurred from days 5 to 9. Graft survival
(Figure 8b) did not differ between animals of groups 4 and 5
(mean survival 8 and 8.1 days, respectively).
In animals receiving allogeneic kidneys stored in Belzer
solution added with PC (1.2 mg/ml) during the 6 h CIT
(group 6), serum creatinine values at 16 h, 24 h, and 2 days
post transplant were significantly lower than values observed
in those of group 5 animals (Po0.05; Figure 8a). In addition,
in this group, rise in mean serum creatinine levels at day 7
post transplant, due to acute rejection, was significantly lower
than in rats of groups 4 and 5 (Po0.01). The survival time
was slightly prolonged in group 6 animals (mean survival 9
days) as compared with animals receiving an untreated
allograft, however the difference did not reach statistical
significance (Figure 8b).
DISCUSSION
In a previous study in a rat syngeneic kidney transplantation
model,24 we documented a protective effect of PC against I/R
injury. This study confirms the protective properties of PC in
a fully allogeneic transplant model, a setting that more closely
mimics the clinical condition. Furthermore, we found that
immunosuppression with CsA did not hamper the action of
PC to protect the graft against I/R damage, which makes our
results even more clinically relevant.
Renal function preservation by PC was documented by
lower serum creatinine levels at early times after transplant in
rats whose graft were treated with PC compared to animals
receiving untreated grafts exposed to CIT. By histological
analysis, we documented a structural preservation of kidneys
stored in Belzer solution added with PC, in particular renal
tubular damage, the most typical feature of I/R injury,8 was
clearly prevented by PC.
Another main finding of this study is that the exposure of
kidneys to cold ischemia had a strong impact on graft
survival. This is in line with clinical observations that, in
kidney transplant recipients, CIT is a negative risk factor for
long term renal allograft survival.2,3 On the other hand, when
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Figure 8 | Effect of PC on acute allograft rejection. (a) Serum creatinine levels (mean±s.d.) and (b) graft survival (%) of BN rats receiving a
Lewis kidney allograft not preexposed to CIT (group 4, white squares, n¼ 4) or preexposed to 6 h CIT in Belzer solution (group 5, black
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group 5, wPo0.05 vs group 5.
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kidneys underwent CIT in the presence of PC, 100% graft
survival was achieved at the end of the observation period,
suggesting that the addition of this drug to preservation
solution might result in improved graft success in human
kidney transplantation.
We then tried to gain insight into the mechanisms
involved in PC protection from I/R damage. Leukocyte
infiltration in response to I/R injury is a well known
phenomenon.28 As in acute inflammation, neutrophils
infiltrate down a concentration gradient of chemotactic
factors such as interleukin-8 and macrophage inflammatory
protein-2, after adherence to endothelial cells through
adhesion molecules.29 In turn, neutrophils release lysosomal
enzymes and superoxide anions, which concur to amplify the
tissue injury.30 In several models of I/R injury, prevention of
granulocyte infiltration resulted in a beneficial effect on
postischemic organ function.31–38 We then analyzed the
degree of granulocyte infiltration and found an increased
number of neutrophils in interstitial areas of all untreated
transplanted kidneys, irrespectively of whether they were or
not exposed to CIT. We speculate that in our model warm
ischemia during surgery was sufficient to trigger signals that
recruited neutrophils and sustained their graft infiltration, as
already observed in experimental models of renal I/R injury
induced by arterial clamping.34,38–42 The slight increase in
tubular damage and the significant raise in serum creatinine
that we observed following warm ischemia, were probably
attributable to the contribution of neutrophil infiltration to
graft dysfunction. PC addition to the Belzer solution
completely prevented intragraft infiltration of neutrophils
as well as CD4þ , CD8þ , ED1þ , and MHC IIþ cells. The
effect of PC on leukocytes was probably secondary to a
protective effect of this drug on renal tissue, so that
inflammatory stimuli such as adhesion molecules and
chemokines triggered by I/R damage were reduced in PC
treated grafts.
The property of PC to modify the molecular dynamics of
the membrane bilayer43 and to stabilize plasma membrane
during ischemia44 could contribute to the protection
observed at tubular cell level. The possibility exists that PC
may protect ischemic tissue by a metabolic effect, related to
an improvement in mitochondrial respiration, as already
described in models of cardiac22 and forebrain ischemia.45
However, other studies in rat isolated perfused kidneys24 and
hearts46 did not find an effect of PC on ATP and energy
charge levels in ischemic tissues. Further studies are needed
to investigate a possible metabolic effect of PC in our
experimental model.
Cytoprotection could also be attributed to direct anti-
oxidant properties of PC as previously reported in vitro47 and
in models of rat forebrain ischemia-induced neuronal
injury,45 in liver and heart of spontaneous hypertensive
rats,48 in rat renal24 and cardiac49,50 I/R injury. According to
this hypothesis, we found that allogeneic grafts treated with
PC were protected from oxidative stress injury that was
instead present in untreated ischemic kidney grafts. Notably,
as observed for neutrophil infiltration, oxidative stress injury
was also present in kidney grafts not exposed to CIT,
indicating that warm ischemia was sufficient to cause
increased lipid peroxidation and that apparently cold
ischemia did not worsen oxidative stress. Although granulo-
cyte infiltration and HNE production were both ameliorated
by PC, they were not different in the cold and warm ischemic
kidneys, so they cannot simply account for the injury
observed.
In this study, we also showed a pro-oxidant pathway
activated by cold but not by warm ischemia in kidney grafts.
Peroxinitrite generation, a phenomenon reflecting the
increased tissue concentration of reactive oxygen species
and nitric oxide,27 occurred specifically in kidneys under-
going CIT, but not in kidneys only exposed to warm ischemia
as demonstrated by nitrotyrosine staining. Accordingly,
mRNA for iNOS—the inducible NO-synthase isoform
expressed in inflammatory cells51 and in renal tissue52,53—
was upregulated in grafts exposed to CIT but not in grafts
only exposed to warm ischemia. We did not investigate the
cell localization of iNOS, however we found nitrotyrosine
staining signals both in resident cells and in inflammatory
infiltrates (data not shown), which suggests that both PMN
and renal cells could contribute to the generation of
peroxinitrite. Altogether these data indicate that cold
ischemia was associated to an enhancement of iNOS
expression and NO release in the graft that combining with
reactive oxygen species released by PMN and by renal tissue
upon warm ischemia could result in the production of
peroxinitrite and tissue damage. We found that PC treatment
inhibited the upregulation of iNOS mRNA in kidney grafts
exposed to cold ischemia and consequently the production of
peroxinitrite. However, we were unable to demonstrate if
there was a direct antioxidant effect of PC or if its various
primary effects in ameliorating the cellular insult could have
contributed to limit the oxidative injury.
It has been hypothesized that ischemic renal injury
increases the risk of acute graft rejection because stimulation
of the innate immunity in response to injury amplifies
adaptive immune response to the allograft.25 Indeed, after I/
R, increased expression of MHC class I and II molecules in
the kidney have been reported, which can elicit a strong
immune response via either the direct or indirect pathway of
allorecognition.54 Tubular cells mainly upregulate MHC class
I antigens, whereas in infiltrating interstitial cells MHC class
II expression increases in response to I/R.55 Ischemic injury
also upregulates intragraft expression of costimulatory
molecules, resulting in increased immunogenicity of trans-
planted organs.35 The possibility that ischemic injury is an
initiating factor in allograft rejection is supported by several
clinical studies that reported an higher incidence of acute
rejection in human kidney allografts with post-transplant
acute tubular necrosis and delayed graft function compared
with allografts with immediate function.56–58 In the fully
mismatched rat kidney transplantation model here reported,
graft survival was not worsened by cold ischemia, suggesting
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that I/R damage did not accelerate acute allograft rejection.
However, in the group of animals receiving PC-treated
ischemic grafts, mean serum creatinine levels due to acute
rejection were significantly lower at 7 days post transplanta-
tion and the graft survival time was slightly prolonged as
compared to rats receiving untreated kidneys either exposed
or not to CIT. These data would suggest that the protective
properties of PC on pathogenetic mechanisms unchained by
both warm and cold ischemia had an effect in reducing the
graft capacity to stimulate T-cell alloreactivity, although this
protection was not enough to block the reaction of rejection
in this fully mismatched model, in the absence of any
immunosuppression.
In conclusion, our results indicate that addition of PC to
the storage Belzer solution during cold ischemia led to
structural and functional graft preservation toward I/R
damage in rat kidney allotransplantation. This benefit was
associated with inhibition of leukocyte recruitment and
reduction of oxidative stress. These results support the
clinical applicability of PC addition to organ storage solution,
which might be useful for the prevention of I/R injury-
induced delayed graft function in kidney transplant patients.
MATERIALS AND METHODS
Animals
Inbred adult male BN rats (RT1n; Charles River Italia Spa, Calco,
Italy) were used as recipients and LW (RT1l) as donors.
Animal care and treatment were conducted in accordance with
institutional guidelines in compliance with national and interna-
tional laws and policies (European Economic Community Council
Directive 86/609). All animals were allowed free access to standard
rat chow and tap water.
Kidney transplantation and graft function evaluation
Kidney transplantation was performed as described previously.24
The donor kidney was flushed with Belzer UW solution containing
1000 U/ml heparin and, according to experimental design, placed or
not in an iced Belzer UW solution for 6 h (CIT) with or without
addition of PC. After ischemia time had elapsed, recipient rats
underwent removal of the native left kidney. Donor kidney grafts
were then washed with saline solution and transplanted. An
anastomosis was created between the donor and recipient renal
artery as well as renal vein with end-to-end anastomosis. Vascular
clamps were released after 30 min (warm ischemia). Donor and
recipient ureters were attached end-to-end. The native right kidney
was then removed. Rejection was defined as animal death or killing
because of moribund state. Serum creatinine levels were measured
by Reflovet (Roche, Mannheim, Germany).24,59
Histological examination
Kidney specimens fixed in Dubosq-Brazil were dehydrated in alcohol.
After paraffin embedding, 3-mm sections of the blocks were cut and
stained with periodic acid-Schiff, Masson’s trichrome, and hematox-
ylin eosin (H and E). Tubular damage—defined as necrosis—was
assessed and graded according to a semiquantitative scale (0–3).24
Immunohistochemistry
To evaluate leukocyte infiltration, indirect immunofluorescence was
performed on frozen sections, with the following antibodies: mouse
anti-rat granulocyte (MOM/3F12/F2; Walter Occhiena, Turin, Italy);
mouse anti-rat CD4 (W3/25; Serotec, Oxford, UK); mouse anti-rat
MHC class II (0X6; Walter Occhiena); mouse anti-rat CD8 (OX8;
Pharmingen, San Diego, CA); mouse anti-rat ED1 (Chemicon,
Temecula, CA). As secondary antibodies, Cy3-conjugated donkey
anti-mouse immunoglobulin G (Jackson ImmunoResearch, West
Grove, PA) were used.
Oxidative damage in renal tissue was localized by specific mouse
monoclonal antibodies against nitrotyrosine (Upstate Biotechnology
Inc., Lake Placid, NY) and 4-HNE-lysine adduct (NA59, kindly
provided by Dr Witzum, The Scripps Research Institute, La Jolla,
CA). Briefly, 3-mm paraffin sections previously fixed with 10%
formalin were incubated with the primary antibody and developed
with diaminobenzidine-nickel. The sections were counterstained
with Harris hematoxylin. Negative controls were incubated with a
nonimmune antibody. Each section was scored for intensity of
immunostaining (absent, faint, moderate, intense: 0–3). At least 8–10
fields per section were examined. The final score per section was
calculated as a weighted mean.
Real-time quantitative PCR
Total RNA was obtained by homogenization of renal tissue followed
by Trizol extraction (Invitrogen, Carlsbad, CA, USA). RNA was
treated with DNase and reverse transcribed to cDNA by Supescript
II (Invitrogen). Quantitative real-time PCR was performed on a
TaqMan ABI Prism 5700 Sequence Detection System (Applied
Biosystems, Foster City, CA USA) with Power Syber Green Master
Mix as previously described.60 The DDCt equation was used to
compare the iNOS gene expression in each sample with the
expression in a pool of three native kidneys, taken as calibrator
(iNOS expression set to 1 arbitrary unit).
Statistical analysis
Results are expressed as mean±s.d. or s.e. as specified in the
figure legends. Data were analyzed using log-rank test,
ANOVA-factorial, or ANOVA-repeated measures for multiple
comparisons as appropriate. Statistical significance was defined as
Po0.05.
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